Francesca Salvianti, Cinzia Pupilli and Pamela Pinzani
Circulating Tumor Cells (CTCs) are considered a liquid biopsy of solid tumors, reflecting the disease complexity at any stage of cancer progression. CTCs, in fact, represent a surrogate material of the tumor which can be obtained by a minimally invasive blood draw and used for disease monitoring and orienting therapeutic decisions, but their detection and characterization are technically challenging.
இந்தக் கட்டுரையைப் பகிரவும்
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 